Related Experiment Video
Updated: Jan 15, 2026
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Differential Hypoxemia During Veno-Arterial Extracorporeal Organ Support: Its Impact on Mortality and Different
Anneke Neumann1,2, Lina Serna Higuita3, Jana Buob1
1Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany.
Objectives:
Extracorporeal Life Support (ECLS) has evolved into an established treatment for severe cardiogenic shock. As most patients have residual antegrade left ventricular output toward the descending aorta that meets the retrograde blood flow from the arterial ECLS cannula, they may develop differential hypoxemia. The location of the mixing cloud is critical for coronary and brain oxygenation. We analyzed the effects of the development of differential hypoxemia on morbidity and mortality of ECLS patients. Moreover, we analyzed the impact of two different treatment options for this phenomenon, including the administration of beta-blockers and the provision of a supplementary arterial cannula, on survival.
Methods:
We performed a retrospective review of patient demographics, outcomes, laboratory, and respiratory parameters during and after ECLS support for 76 ECLS patients treated at our institution.
Results:
Overall, 38 ECLS patients developed differential hypoxemia. Treatment of this phenomenon included either the administration of beta-blockers (n = 18) or the introduction of a second arterial ECLS cannula (n = 20). There were no significant differences in median SOFA-Scores (Sequential Organ Failure Assessment Scores) between groups (p = 0.072; ECLS vs. ECLS with differential hypoxemia patients). Under all respiratory and laboratory values analyzed, only bilirubin levels were significantly different (p = 0.020). Development of differential hypoxemia was associated with significantly decreased survival rates (p = 0.05). Moreover, insertion of a second arterial ECLS cannula was a risk factor for mortality (OR: 3.68, 95% CI 1.18-11.47, p = 0.025).
Conclusions:
Development of differential hypoxemia is associated with significantly increased mortality rates among ECLS patients and should therefore be prevented as far as possible. Non-invasive administration of beta-blockers seems to be the more effective treatment option for differential hypoxemia, as the introduction of a second arterial ECLS cannula was a risk factor for mortality.
Related Concept Videos
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
01:23Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:20Respiration and Gaseous Exchange
Respiration involves the exchange of gases, especially oxygen (O2) and carbon dioxide (CO2), between the alveoli and body cells, a process facilitated by blood circulation. As a result, the cardiovascular system, which involves...